Catalyst Wire Dossier Catalyst Wire Dossier

Dalfampridine (generic)

dalfampridine · Actavis Pharma, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Dalfampridine (generic), covering 2017-01-23 to 2017-01-23. Get the full timeline:

Most recent: FDA Approved: DALFAMPRIDINE — Original Application (Actavis Pharma, Inc.)

See pricing